EVA1A and plasma cell myeloma: Previous studies have revealed that, compared to normal tissues, EVA1A is down-regulated in various human tumors, such as pituitary adenoma, myeloma, adrenocortical, pancreatic and hepatocellular carcinomas, as well as gastric, esophageal and lung cancers 39-45.